Upregulation of long noncoding RNA LOC100507661 promotes tumor aggressiveness in thyroid cancer

Molecular and Cellular Endocrinology

Volumn 431, Issue , 2016, Pages 36-45

  Kim, Daham ^a,b   Lee, Woo Kyung ^a,b   Jeong, Seonhyang ^a   Seol, Mi Youn ^a   Kim, Hyunji ^a   Kim, Kyung Sup ^a,b   Lee, Eun Jig ^a,b   Lee, Jandee ^a,c   Jo, Young Suk ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Carcinogenesis; LOC100507661; Long noncoding RNA; Thyroid cancer

Indexed keywords

LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA LOC100507661; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; CANCER CELL LINE; CARCINOGENESIS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLORIMETRY; CONTROLLED STUDY; COPY NUMBER VARIATION; DOWN REGULATION; EXON; EXPRESSION VECTOR; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CANCER; TUMOR INVASION; TUMOR PROMOTION; UPREGULATION; CELL LINE; CELL MOTION; GENETICS; LYMPH NODE METASTASIS; PATHOLOGY; THYROID TUMOR; TUMOR CELL LINE;

CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, LONG NONCODING; THYROID NEOPLASMS; UP-REGULATION;

EID: 84966706409     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2016.05.002     Document Type: Article

References (36)

1. Barsyte-Lovejoy D., Lau S.K., Boutros P.C., Khosravi F., Jurisica I., Andrulis I.L., et al. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 2006, 66(10):5330-5337.
2. Cancer Genome Atlas Research Network Integrated genomic characterization of papillary thyroid carcinoma. Cell 2014, 159(3):676-690.
3. Cancer Genome Atlas Research Network, Weinstein J.N., Collisson E.A., Mills G.B., Shaw K.R., Ozenberger B.A., et al. The cancer genome atlas pan-cancer analysis project. Nat. Genet. 2013, 45(10):1113-1120.
4. Chunharojrith P., Nakayama Y., Jiang X., Kery R.E., Ma J., De La Hoz Ulloa C.S., et al. Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line. Mol. Cell. Endocrinol. 2015, 416:27-35.
5. Cohen Y., Xing M., Mambo E., Guo Z., Wu G., Trink B., et al. BRAF mutation in papillary thyroid carcinoma. J. Natl. Cancer Inst. 2003, 95(8):625-627.
6. Davies L., Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. Jama 2006, 295(18):2164-2167.
7. Derrien T., Johnson R., Bussotti G., Tanzer A., Djebali S., Tilgner H., et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012, 22(9):1775-1789.
8. Fagin J.A. How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy. J. Endocrinol. 2004, 183(2):249-256.
9. Fusco D., Accornero N., Lavoie B., Shenoy S.M., Blanchard J.M., Singer R.H., et al. Single mRNA molecules demonstrate probabilistic movement in living mammalian cells. Curr. Biol. CB 2003, 13(2):161-167.
10. Haugen B.R.M., Alexander E.K., Bible K.C., Doherty G., Mandel S.J., Nikiforov Y.E., et al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid Off. J. Am. Thyroid Assoc. 2015, 2015.
11. He H., Li W., Liyanarachchi S., Jendrzejewski J., Srinivas M., Davuluri R.V., et al. Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2. J. Clin. Endocrinol. Metab. 2015, 100(1):E164-E172.
12. He H., Nagy R., Liyanarachchi S., Jiao H., Li W., Suster S., et al. A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res. 2009, 69(2):625-631.
13. Hu X., Feng Y., Zhang D., Zhao S.D., Hu Z., Greshock J., et al. A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell 2014, 26(3):344-357.
14. Hwang T.S. Molecular diagnosis for cytologically indeterminate thyroid nodules. Int. J. Thyroidol. 2015, 8(2):153-160.
15. International Human Genome Sequencing Consortium Finishing the euchromatic sequence of the human genome. Nature 2004, 431(7011):931-945.
16. Jendrzejewski J., He H., Radomska H.S., Li W., Tomsic J., Liyanarachchi S., et al. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(22):8646-8651.
17. Jendrzejewski J., Thomas A., Liyanarachchi S., Eiterman A., Tomsic J., He H., et al. PTCSC3 is involved in papillary thyroid carcinoma development by modulating S100A4 gene expression. J. Clin. Endocrinol. Metab. 2015, 100(10). E1370-1377.
18. Ji P., Diederichs S., Wang W., Boing S., Metzger R., Schneider P.M., et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22(39):8031-8041.
19. Kim J.G. Molecular pathogenesis and targeted therapies in well-differentiated thyroid carcinoma. Endocrinol. Metab. 2014, 29(3):211-216.
20. Kim S.J., Choi I.J., Cheong T.C., Lee S.J., Lotan R., Park S.H., et al. Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression. Gastroenterology 2010, 138(3):1035-1045. e1031-1032.
21. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 2009, 10(2):126-139.
22. Li J., Han L., Roebuck P., Diao L., Liu L., Yuan Y., et al. TANRIC: an interactive open platform to explore the function of lncRNAs in Cancer. Cancer Res. 2015, 75(18):3728-3737.
23. Liu X., Bishop J., Shan Y., Pai S., Liu D., Murugan A.K., et al. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr. Related Cancer 2013, 20(4):603-610.
24. Mercer T.R., Mattick J.S. Structure and function of long noncoding RNAs in epigenetic regulation. Nat. Struct. Mol. Biol. 2013, 20(3):300-307.
25. Nikiforov Y.E., Carty S.E., Chiosea S.I., Coyne C., Duvvuri U., Ferris R.L., et al. Impact of the multi-gene ThyroSeq next-generation sequencing assay on cancer diagnosis in thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance cytology. Thyroid Off. J. Am. Thyroid Assoc. 2015, 25(11):1217-1223.
26. Park J.H., Lee K.S., Bae K.-S., Kang S.J. Regional lymph node metastasis in papillary thyroid Cancer. J. Korean Thyroid. Assoc. 2014, 7(2):129-135.
27. Perez C.A., Santos E.S., Arango B.A., Raez L.E., Cohen E.E. Novel molecular targeted therapies for refractory thyroid cancer. Head Neck 2012, 34(5):736-745.
28. Prensner J.R., Chinnaiyan A.M. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011, 1(5):391-407.
29. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129(7):1311-1323.
30. Sato K., Hamada M., Asai K., Mituyama T. CENTROIDFOLD: a web server for RNA secondary structure prediction. Nucleic Acids Res. 2009, 37(Web Server issue):W277-W280.
31. Tripathi V., Shen Z., Chakraborty A., Giri S., Freier S.M., Wu X., et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 2013, 9(3):e1003368.
32. Venkatesh T., Suresh P.S., Tsutsumi R. Non-coding RNAs: functions and applications in endocrine-related cancer. Mol. Cell. Endocrinol. 2015, 416:88-96.
33. Wahlestedt C. Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat. Rev. Drug Discov. 2013, 12(6):433-446.
34. Wang K.C., Chang H.Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 2011, 43(6):904-914.
35. Wang Y., Guo Q., Zhao Y., Chen J., Wang S., Hu J., et al. BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma. Oncol. Lett. 2014, 8(5):1947-1952.
36. Yoon H., He H., Nagy R., Davuluri R., Suster S., Schoenberg D., et al. Identification of a novel noncoding RNA gene, NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest. Int. J. Cancer. J. Int. du Cancer 2007, 121(4):767-775.